# A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

> **NCT06958536** · PHASE2 · RECRUITING · sponsor: **Sanofi** · enrollment: 99 (estimated)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** SAR442970
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06958536
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-03
- **Primary completion:** 2026-12-17
- **Final completion:** 2029-10-17
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06958536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06958536, "A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06958536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*